canertinib dihydrochloride has been researched along with Clostridium Infections in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Behnke, M; Dinkelacker, A; Eisenbeis, S; Falgenhauer, J; Gastmeier, P; Häcker, G; Herold, S; Imirzalioglu, C; Jazmati, N; Käding, N; Kern, WV; Kramme, E; Mischnik, A; Peter, S; Piepenbrock, E; Rohde, AM; Rupp, J; Schneider, C; Schwab, F; Seifert, H; Steib-Bauert, M; Tacconelli, E; Trauth, J; Vehreschild, MJGT; Walker, SV | 1 |
1 other study(ies) available for canertinib dihydrochloride and Clostridium Infections
| Article | Year |
|---|---|
Association of ward-level antibiotic consumption with healthcare-associated Clostridioides difficile infections: an ecological study in five German university hospitals, 2017-2019.
Topics: Anti-Bacterial Agents; Carbapenems; Clostridioides difficile; Clostridium Infections; Cross Infection; Hospitals, University; Humans; Incidence; Retrospective Studies | 2023 |